Dr. Bowen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9300 Stockdale Hwy
Ste 300
Bakersfield, CA 93311Phone+1 760-837-7200Fax+1 760-837-7201
Education & Training
University of Southern California/LAC+USC Medical CenterFellowship, Hand Surgery (Plastic Surgery), 1996 - 1997
Methodist Hospital (Houston)Residency, Plastic Surgery, 1994 - 1996
Baylor College of MedicineResidency, Surgery, 1992 - 1994- Baylor College of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1996 - 2026
UT State Medical License 2024 - 2026
TX State Medical License 1992 - 1997- American Board of Plastic Surgery Plastic Surgery
Clinical Trials
- Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia Start of enrollment: 2010 Jan 01
Publications & Presentations
PubMed
- 241 citationsResults of the phase i trial of RG7112, a small-molecule MDM2 antagonist in leukemiaMichael Andreeff, Kevin R. Kelly, Karen W.L. Yee, Sarit Assouline, Roger Strair
Clinical Cancer Research. 2016-02-15 - 183 citationsRAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.David T. Bowen, Marion E. Frew, Robert Kerrin Hills, Rosemary E. Gale, Keith Wheatley
Blood. 2005-09-15 - 1062 citationsThe presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and re...Panagiotis D. Kottaridis, Rosemary E. Gale, Marion E. Frew, G Harrison, Stephen E. Langabeer
Blood. 2001-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
